Belgium-based biopharmaceutical company developing and commercializing prescription medicines for animals
Belgium-based biopharmaceutical company developing and commercializing prescription medicines for animals. Its proprietary pet therapeutics platform included clinical and development-stage antiviral candidates for feline herpesvirus and feline immunodeficiency virus, as well as additional antiviral and oncology candidates for cats and dogs.